Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-06-15 Sale |
2020-06-16 6:14 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $43.45 | $173,811 | 1,746,356 (Indirect) |
View |
2020-06-04 Sale |
2020-06-05 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $41.61 | $166,444 | 1,750,356 (Indirect) |
View |
2020-05-27 Sale |
2020-05-29 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $39.01 | $1,950,460 | 1,754,356 (Indirect) |
View |
2020-05-26 Sale |
2020-05-27 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Ahmed Mahiuddin Sr. VP and CSO |
50,000 | $39.38 | $1,969,235 | 150,000 (Direct) |
View |
2020-05-18 Sale |
2020-05-20 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $39.65 | $158,596 | 1,804,356 (Indirect) |
View |
2020-05-18 Sale |
2020-05-20 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Ahmed Mahiuddin Sr. VP and CSO |
29,492 | $39.4 | $1,162,078 | 200,000 (Direct) |
View |
2020-05-13 Sale |
2020-05-15 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Moller-San Pedro Claus Juan Chief Executive Officer |
200,000 | $36.55 | $7,310,120 | 674,828 (Indirect Direct) |
View |
2020-05-13 Sale |
2020-05-15 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secy & Treas. |
100,000 | $36.65 | $3,665,321 | 257,077 (Indirect Direct) |
View |
2020-05-13 Sale |
2020-05-15 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Ahmed Mahiuddin Sr. VP & Chief Scientific Off |
10,508 | $37.64 | $395,563 | 229,492 (Direct) |
View |
2020-05-12 Sale |
2020-05-14 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $39.04 | $1,951,935 | 1,808,356 (Indirect) |
View |
2020-05-12 Sale |
2020-05-13 4:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | Ahmed Mahiuddin Sr. VP and CSO |
20,000 | $39.19 | $783,776 | 240,000 (Direct) |
View |
2020-05-01 Sale |
2020-05-05 4:17 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $32.35 | $129,404 | 1,858,356 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-06-23 Option Award |
2020-06-24 4:48 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,000 | $0 | 16,000 (Direct) |
View |
2020-06-23 Option Award |
2020-06-24 4:47 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | HEALY JAMES Director |
16,000 | $0 | 16,000 (Direct) |
View |
2020-06-23 Option Award |
2020-06-24 4:47 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Ber Gerard Director |
16,000 | $0 | 16,000 (Direct) |
View |
2020-06-23 Option Award |
2020-06-24 4:46 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,000 | $0 | 16,000 (Direct) |
View |
2020-06-23 Option Award |
2020-06-24 4:46 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | TYAGI ASHU Director |
48,000 | $0 | 48,000 (Direct) |
View |